Direct gamete uterine transfer in patients with tubal absence or occlusion
Our aim was to examine the potential of the uterine cavity to affect fertilization and early embryo development. A prospective IRB-approved protocol for patients fulfilling study eligibility criteria was used. Patients studied included those with primary or secondary infertility, aged less than 38 y...
Gespeichert in:
Veröffentlicht in: | Journal of assisted reproduction and genetics 1997, Vol.14 (1), p.35-38 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 38 |
---|---|
container_issue | 1 |
container_start_page | 35 |
container_title | Journal of assisted reproduction and genetics |
container_volume | 14 |
creator | RANSOM, M. X GARCIA, A. J DOHERTY, K SHELDEN, R KEMMANN, E |
description | Our aim was to examine the potential of the uterine cavity to affect fertilization and early embryo development.
A prospective IRB-approved protocol for patients fulfilling study eligibility criteria was used.
Patients studied included those with primary or secondary infertility, aged less than 38 years, with no history of severe male-factor infertility, and with hysterosalpingogram- and laparoscopic-confirmed bilateral proximal tubal occlusion. Superovulation induction was accomplished with a combination of GnRH agonist and menotropins, with serum hormonal and sonographic monitoring. Within 24 hr prior to, and again at the time of, ovulatory hCG administration, progesterone (P4) was given. Sonographic-guided transvaginal retrieval was performed 35 hr after hCG. Between four and six oocytes were returned to the uterine cavity, admixed with sperm, immediately following retrieval. Luteal support consisted of daily P4 administration.
Of the 20 patients recruited for the study, all completed the retrieval and transfer procedure. A total of four clinical pregnancies was achieved, with one early first-trimester loss, one late first-trimester loss (Trisomy 14), and two healthy term infants delivered. IVF of surplus oocytes demonstrated a 82.5% fertilization rate and 66.7% cleavage following cryopreservation.
Human fertilization can be achieved through direct uterine transfer of gametes. Furthermore, administration of P4 prior to the ovulatory dose of hCG is compatible with in vitro or in vivo fertilization and implantation. |
doi_str_mv | 10.1007/BF02765750 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3454710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78809863</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-736ca15548291320bdf550e284255a72f7bd69771e4f36aea52f3866a929cbf93</originalsourceid><addsrcrecordid>eNpVkM9rFDEYhoNU1rZ68S7kUDwUVr8kk2TmUuivrUrBi57DN9kvbWR2Zk0yiv-9Kbus9ZQP3oc3Lw9jbwV8EAD249UKpDXaanjBjoW2ammVgqN6g26X0Jj2FTvJ-QcAdK1UC7boQFSiO2ZfbmIiX_gDbqgQnwulOBIvCcccKPE48i2WSGPJ_Hcsj7zMPQ4c-0yjJz4lPnk_zDlO42v2MuCQ6c3-PWXfV7ffrj8t77_efb6-vF_6BmSp04xHoXXTyk4oCf06aA0k20ZqjVYG269NZ62gJiiDhFoG1RqDnex8Hzp1yi52vdu539Da120JB7dNcYPpj5swuv-TMT66h-mXU41urIBa8H5fkKafM-XiNjF7GgYcaZqzs21bPRlVwfMd6NOUc6Jw-ESAezLv_pmv8Lvnsw7oXnXNz_Y5Zo9DqIZ9zAdMViHCGvUXXAWLAw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78809863</pqid></control><display><type>article</type><title>Direct gamete uterine transfer in patients with tubal absence or occlusion</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>PubMed Central</source><creator>RANSOM, M. X ; GARCIA, A. J ; DOHERTY, K ; SHELDEN, R ; KEMMANN, E</creator><creatorcontrib>RANSOM, M. X ; GARCIA, A. J ; DOHERTY, K ; SHELDEN, R ; KEMMANN, E</creatorcontrib><description>Our aim was to examine the potential of the uterine cavity to affect fertilization and early embryo development.
A prospective IRB-approved protocol for patients fulfilling study eligibility criteria was used.
Patients studied included those with primary or secondary infertility, aged less than 38 years, with no history of severe male-factor infertility, and with hysterosalpingogram- and laparoscopic-confirmed bilateral proximal tubal occlusion. Superovulation induction was accomplished with a combination of GnRH agonist and menotropins, with serum hormonal and sonographic monitoring. Within 24 hr prior to, and again at the time of, ovulatory hCG administration, progesterone (P4) was given. Sonographic-guided transvaginal retrieval was performed 35 hr after hCG. Between four and six oocytes were returned to the uterine cavity, admixed with sperm, immediately following retrieval. Luteal support consisted of daily P4 administration.
Of the 20 patients recruited for the study, all completed the retrieval and transfer procedure. A total of four clinical pregnancies was achieved, with one early first-trimester loss, one late first-trimester loss (Trisomy 14), and two healthy term infants delivered. IVF of surplus oocytes demonstrated a 82.5% fertilization rate and 66.7% cleavage following cryopreservation.
Human fertilization can be achieved through direct uterine transfer of gametes. Furthermore, administration of P4 prior to the ovulatory dose of hCG is compatible with in vitro or in vivo fertilization and implantation.</description><identifier>ISSN: 1058-0468</identifier><identifier>EISSN: 1573-7330</identifier><identifier>DOI: 10.1007/BF02765750</identifier><identifier>PMID: 9013309</identifier><identifier>CODEN: JARGE4</identifier><language>eng</language><publisher>New York, NY: Kluwer/Plenum</publisher><subject>Adult ; Biological and medical sciences ; Birth control ; Chorionic Gonadotropin - therapeutic use ; Clinical Assisted Reproduction ; Cryopreservation ; Embryo Transfer - methods ; Fallopian Tube Diseases - therapy ; Fallopian Tubes - pathology ; Female ; Follicle Stimulating Hormone - therapeutic use ; Gynecology. Andrology. Obstetrics ; Humans ; Infertility, Female - therapy ; Male ; Medical sciences ; Oocyte Donation - methods ; Ovulation Induction ; Pregnancy ; Pregnancy Rate ; Progesterone - therapeutic use ; Spermatozoa ; Sterility. Assisted procreation ; Uterus - physiology</subject><ispartof>Journal of assisted reproduction and genetics, 1997, Vol.14 (1), p.35-38</ispartof><rights>1997 INIST-CNRS</rights><rights>Plenum Publishing Corporation 1997</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-736ca15548291320bdf550e284255a72f7bd69771e4f36aea52f3866a929cbf93</citedby><cites>FETCH-LOGICAL-c402t-736ca15548291320bdf550e284255a72f7bd69771e4f36aea52f3866a929cbf93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454710/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454710/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,27900,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2548176$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9013309$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RANSOM, M. X</creatorcontrib><creatorcontrib>GARCIA, A. J</creatorcontrib><creatorcontrib>DOHERTY, K</creatorcontrib><creatorcontrib>SHELDEN, R</creatorcontrib><creatorcontrib>KEMMANN, E</creatorcontrib><title>Direct gamete uterine transfer in patients with tubal absence or occlusion</title><title>Journal of assisted reproduction and genetics</title><addtitle>J Assist Reprod Genet</addtitle><description>Our aim was to examine the potential of the uterine cavity to affect fertilization and early embryo development.
A prospective IRB-approved protocol for patients fulfilling study eligibility criteria was used.
Patients studied included those with primary or secondary infertility, aged less than 38 years, with no history of severe male-factor infertility, and with hysterosalpingogram- and laparoscopic-confirmed bilateral proximal tubal occlusion. Superovulation induction was accomplished with a combination of GnRH agonist and menotropins, with serum hormonal and sonographic monitoring. Within 24 hr prior to, and again at the time of, ovulatory hCG administration, progesterone (P4) was given. Sonographic-guided transvaginal retrieval was performed 35 hr after hCG. Between four and six oocytes were returned to the uterine cavity, admixed with sperm, immediately following retrieval. Luteal support consisted of daily P4 administration.
Of the 20 patients recruited for the study, all completed the retrieval and transfer procedure. A total of four clinical pregnancies was achieved, with one early first-trimester loss, one late first-trimester loss (Trisomy 14), and two healthy term infants delivered. IVF of surplus oocytes demonstrated a 82.5% fertilization rate and 66.7% cleavage following cryopreservation.
Human fertilization can be achieved through direct uterine transfer of gametes. Furthermore, administration of P4 prior to the ovulatory dose of hCG is compatible with in vitro or in vivo fertilization and implantation.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Birth control</subject><subject>Chorionic Gonadotropin - therapeutic use</subject><subject>Clinical Assisted Reproduction</subject><subject>Cryopreservation</subject><subject>Embryo Transfer - methods</subject><subject>Fallopian Tube Diseases - therapy</subject><subject>Fallopian Tubes - pathology</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - therapeutic use</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Infertility, Female - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Oocyte Donation - methods</subject><subject>Ovulation Induction</subject><subject>Pregnancy</subject><subject>Pregnancy Rate</subject><subject>Progesterone - therapeutic use</subject><subject>Spermatozoa</subject><subject>Sterility. Assisted procreation</subject><subject>Uterus - physiology</subject><issn>1058-0468</issn><issn>1573-7330</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM9rFDEYhoNU1rZ68S7kUDwUVr8kk2TmUuivrUrBi57DN9kvbWR2Zk0yiv-9Kbus9ZQP3oc3Lw9jbwV8EAD249UKpDXaanjBjoW2ammVgqN6g26X0Jj2FTvJ-QcAdK1UC7boQFSiO2ZfbmIiX_gDbqgQnwulOBIvCcccKPE48i2WSGPJ_Hcsj7zMPQ4c-0yjJz4lPnk_zDlO42v2MuCQ6c3-PWXfV7ffrj8t77_efb6-vF_6BmSp04xHoXXTyk4oCf06aA0k20ZqjVYG269NZ62gJiiDhFoG1RqDnex8Hzp1yi52vdu539Da120JB7dNcYPpj5swuv-TMT66h-mXU41urIBa8H5fkKafM-XiNjF7GgYcaZqzs21bPRlVwfMd6NOUc6Jw-ESAezLv_pmv8Lvnsw7oXnXNz_Y5Zo9DqIZ9zAdMViHCGvUXXAWLAw</recordid><startdate>1997</startdate><enddate>1997</enddate><creator>RANSOM, M. X</creator><creator>GARCIA, A. J</creator><creator>DOHERTY, K</creator><creator>SHELDEN, R</creator><creator>KEMMANN, E</creator><general>Kluwer/Plenum</general><general>Springer US</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>1997</creationdate><title>Direct gamete uterine transfer in patients with tubal absence or occlusion</title><author>RANSOM, M. X ; GARCIA, A. J ; DOHERTY, K ; SHELDEN, R ; KEMMANN, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-736ca15548291320bdf550e284255a72f7bd69771e4f36aea52f3866a929cbf93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Birth control</topic><topic>Chorionic Gonadotropin - therapeutic use</topic><topic>Clinical Assisted Reproduction</topic><topic>Cryopreservation</topic><topic>Embryo Transfer - methods</topic><topic>Fallopian Tube Diseases - therapy</topic><topic>Fallopian Tubes - pathology</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - therapeutic use</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Infertility, Female - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Oocyte Donation - methods</topic><topic>Ovulation Induction</topic><topic>Pregnancy</topic><topic>Pregnancy Rate</topic><topic>Progesterone - therapeutic use</topic><topic>Spermatozoa</topic><topic>Sterility. Assisted procreation</topic><topic>Uterus - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RANSOM, M. X</creatorcontrib><creatorcontrib>GARCIA, A. J</creatorcontrib><creatorcontrib>DOHERTY, K</creatorcontrib><creatorcontrib>SHELDEN, R</creatorcontrib><creatorcontrib>KEMMANN, E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of assisted reproduction and genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RANSOM, M. X</au><au>GARCIA, A. J</au><au>DOHERTY, K</au><au>SHELDEN, R</au><au>KEMMANN, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct gamete uterine transfer in patients with tubal absence or occlusion</atitle><jtitle>Journal of assisted reproduction and genetics</jtitle><addtitle>J Assist Reprod Genet</addtitle><date>1997</date><risdate>1997</risdate><volume>14</volume><issue>1</issue><spage>35</spage><epage>38</epage><pages>35-38</pages><issn>1058-0468</issn><eissn>1573-7330</eissn><coden>JARGE4</coden><abstract>Our aim was to examine the potential of the uterine cavity to affect fertilization and early embryo development.
A prospective IRB-approved protocol for patients fulfilling study eligibility criteria was used.
Patients studied included those with primary or secondary infertility, aged less than 38 years, with no history of severe male-factor infertility, and with hysterosalpingogram- and laparoscopic-confirmed bilateral proximal tubal occlusion. Superovulation induction was accomplished with a combination of GnRH agonist and menotropins, with serum hormonal and sonographic monitoring. Within 24 hr prior to, and again at the time of, ovulatory hCG administration, progesterone (P4) was given. Sonographic-guided transvaginal retrieval was performed 35 hr after hCG. Between four and six oocytes were returned to the uterine cavity, admixed with sperm, immediately following retrieval. Luteal support consisted of daily P4 administration.
Of the 20 patients recruited for the study, all completed the retrieval and transfer procedure. A total of four clinical pregnancies was achieved, with one early first-trimester loss, one late first-trimester loss (Trisomy 14), and two healthy term infants delivered. IVF of surplus oocytes demonstrated a 82.5% fertilization rate and 66.7% cleavage following cryopreservation.
Human fertilization can be achieved through direct uterine transfer of gametes. Furthermore, administration of P4 prior to the ovulatory dose of hCG is compatible with in vitro or in vivo fertilization and implantation.</abstract><cop>New York, NY</cop><pub>Kluwer/Plenum</pub><pmid>9013309</pmid><doi>10.1007/BF02765750</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1058-0468 |
ispartof | Journal of assisted reproduction and genetics, 1997, Vol.14 (1), p.35-38 |
issn | 1058-0468 1573-7330 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3454710 |
source | MEDLINE; Springer Nature - Complete Springer Journals; PubMed Central |
subjects | Adult Biological and medical sciences Birth control Chorionic Gonadotropin - therapeutic use Clinical Assisted Reproduction Cryopreservation Embryo Transfer - methods Fallopian Tube Diseases - therapy Fallopian Tubes - pathology Female Follicle Stimulating Hormone - therapeutic use Gynecology. Andrology. Obstetrics Humans Infertility, Female - therapy Male Medical sciences Oocyte Donation - methods Ovulation Induction Pregnancy Pregnancy Rate Progesterone - therapeutic use Spermatozoa Sterility. Assisted procreation Uterus - physiology |
title | Direct gamete uterine transfer in patients with tubal absence or occlusion |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T17%3A23%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct%20gamete%20uterine%20transfer%20in%20patients%20with%20tubal%20absence%20or%20occlusion&rft.jtitle=Journal%20of%20assisted%20reproduction%20and%20genetics&rft.au=RANSOM,%20M.%20X&rft.date=1997&rft.volume=14&rft.issue=1&rft.spage=35&rft.epage=38&rft.pages=35-38&rft.issn=1058-0468&rft.eissn=1573-7330&rft.coden=JARGE4&rft_id=info:doi/10.1007/BF02765750&rft_dat=%3Cproquest_pubme%3E78809863%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78809863&rft_id=info:pmid/9013309&rfr_iscdi=true |